David V Goeddel - Net Worth and Insider Trading

David V Goeddel Net Worth

The estimated net worth of David V Goeddel is at least $86 Million dollars as of 2024-12-26. David V Goeddel is the Director, 10% Owner of Tenaya Therapeutics Inc and owns about 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $38 Million. David V Goeddel is the Director, 10% Owner of NGM Biopharmaceuticals Inc and owns about 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $34 Million. David V Goeddel is also the Director, 10% Owner of RAPT Therapeutics Inc and owns about 6,777,151 shares of RAPT Therapeutics Inc (RAPT) stock worth over $14 Million. Details can be seen in David V Goeddel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David V Goeddel has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David V Goeddel

David V Goeddel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David V Goeddel owns 11 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .

Click here to see the complete history of David V Goeddel’s form 4 insider trades.

Insider Ownership Summary of David V Goeddel

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2021-08-18	10 percent owner
NGM	NGM Biopharmaceuticals Inc	2023-11-16	director & 10 percent owner
NRIX	Nurix Therapeutics Inc	2021-05-07	10 percent owner
		2020-11-16	10 percent owner
		2021-11-12	10 percent owner
		2020-03-19	10 percent owner & other: Managing Partner
		2019-04-02	10 percent owner & other: Managing Partner
		2018-09-27	other: Managing Partner
		2018-03-14	10 percent owner
		2021-08-25	10 percent owner
		2024-02-12	director & 10 percent owner

David V Goeddel Latest Holdings Summary

David V Goeddel currently owns a total of 3 stocks. Among these stocks, David V Goeddel owns 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) as of February 12, 2024, with a value of $38 Million and a weighting of 44.51%. David V Goeddel owns 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) as of November 16, 2023, with a value of $34 Million and a weighting of 39.64%. David V Goeddel also owns 6,777,151 shares of RAPT Therapeutics Inc (RAPT) as of November 4, 2019, with a value of $14 Million and a weighting of 15.85%.

Latest Holdings of David V Goeddel

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TNYA	Tenaya Therapeutics Inc	2024-02-12	22,999,565	1.66	38,064,280
NGM	NGM Biopharmaceuticals Inc	2023-11-16	22,008,593	1.54	33,893,233
RAPT	RAPT Therapeutics Inc	2019-11-04	6,777,151	2.00	13,554,302

Holding Weightings of David V Goeddel

David V Goeddel Form 4 Trading Tracker

According to the SEC Form 4 filings, David V Goeddel has made a total of 6 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,222,222 shares on February 12, 2024, which cost David V Goeddel around $10 Million.

According to the SEC Form 4 filings, David V Goeddel has made a total of 31 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 31 buys and 0 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 26,811 shares on November 16, 2023, which cost David V Goeddel around $18,232.

According to the SEC Form 4 filings, David V Goeddel has made a total of 0 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years. The most-recent trade in RAPT Therapeutics Inc is the acquisition of 625,000 shares on November 4, 2019, which cost David V Goeddel around $8 Million.

Insider Trading History of David V Goeddel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David V Goeddel Trading Performance

GuruFocus tracks the stock performance after each of David V Goeddel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David V Goeddel is 26.3%. GuruFocus also compares David V Goeddel's trading performance to market benchmark return within the same time period. The performance of stocks bought by David V Goeddel within 3 months outperforms 39 times out of 61 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David V Goeddel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David V Goeddel

Average Return

Average return per transaction

Outperforming Transactions

36 out of 59 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	11.59
Relative Return to S&P 500(%)	11.26

David V Goeddel Ownership Network

Ownership Network List of David V Goeddel

No Data

Ownership Network Relation of David V Goeddel

David V Goeddel Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

David V Goeddel is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

David V Goeddel is the director & 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include 10 percent owner Column Group L P , Chief Financial Officer Jean-frederic Viret , and Principal Accounting Officer Irene Perlich .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, David V Goeddel made 1 insider transaction in NGM Biopharmaceuticals Inc (NGM) with a net purchase of 26,811. Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P ,

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

David V Goeddel is the 10 percent owner of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 73,087 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 37,393 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 37,393 shares. During the past 18 months, 169,812 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 169,812 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nurix Therapeutics Inc Insider Transactions

No Available Data

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

David V Goeddel is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , See Remarks Margaret A Horn , and Chief Financial Officer Jack Anders .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 36,958 shares made by Jeff Cislini , a net sale of 205,618 shares made by Stephen Michael Kelsey , and a net sale of 277,386 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 253,026 shares of Revolution Medicines Inc (RVMD) in total and bought 1,304,347 shares, with a net purchase of 1,051,321 shares. During the past 18 months, 756,463 shares of Revolution Medicines Inc (RVMD) were sold and 1,304,347 shares were bought by its insiders, resulting in a net purchase of 547,884 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does ORIC Pharmaceuticals Inc do?

Who are the key executives at ORIC Pharmaceuticals Inc?

David V Goeddel is the 10 percent owner of ORIC Pharmaceuticals Inc. Other key executives at ORIC Pharmaceuticals Inc include Chief Business Officer Pratik S Multani , Chief Financial Officer Dominic Piscitelli , and director & President and CEO Jacob Chacko .

ORIC Pharmaceuticals Inc (ORIC) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in ORIC Pharmaceuticals Inc (ORIC). Other recent insider transactions involving ORIC Pharmaceuticals Inc (ORIC) include a net sale of 139,199 shares made by Jacob Chacko , a net sale of 14,133 shares made by Dominic Piscitelli , and a net sale of 14,132 shares made by Pratik S Multani .

In summary, during the past 3 months, insiders sold 42,361 shares of ORIC Pharmaceuticals Inc (ORIC) in total and bought 0 shares, with a net sale of 42,361 shares. During the past 18 months, 167,464 shares of ORIC Pharmaceuticals Inc (ORIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 167,464 shares.

ORIC Pharmaceuticals Inc (ORIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

ORIC Pharmaceuticals Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

David V Goeddel is the 10 percent owner & other: Managing Partner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

David V Goeddel is the 10 percent owner & other: Managing Partner of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

What does Gritstone Bio Inc do?

Who are the key executives at Gritstone Bio Inc?

David V Goeddel is the other: Managing Partner of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .

Gritstone Bio Inc (GRTSQ) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in Gritstone Bio Inc (GRTSQ). Other recent insider transactions involving Gritstone Bio Inc (GRTSQ) include a net sale of 25,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .

In summary, during the past 3 months, insiders sold 12,000 shares of Gritstone Bio Inc (GRTSQ) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 86,769 shares of Gritstone Bio Inc (GRTSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,769 shares.

Gritstone Bio Inc (GRTSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gritstone Bio Inc Insider Transactions

No Available Data

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

David V Goeddel is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include Chief Accounting Officer Alexander Azoy , See Remarks Jennifer Jarrett , and director & 10 percent owner & President Juan C. Jaen .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 171,515 shares made by Jennifer Jarrett , a net sale of 1,840 shares made by Alexander Azoy , and a net purchase of 16,248,095 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 201 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 201 shares. During the past 18 months, 209,366 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 16,038,729 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcus Biosciences Inc Insider Transactions

No Available Data

What does eFFECTOR Therapeutics Inc do?

Who are the key executives at eFFECTOR Therapeutics Inc?

David V Goeddel is the 10 percent owner of eFFECTOR Therapeutics Inc. Other key executives at eFFECTOR Therapeutics Inc include 10 percent owner Sr One Capital Fund I Aggregator Lp , director & 10 percent owner & Chief Executive Officer Christopher B Ehrlich , and Chief Business Officer Mayank Gandhi .

eFFECTOR Therapeutics Inc (EFTR) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in eFFECTOR Therapeutics Inc (EFTR). Other recent insider transactions involving eFFECTOR Therapeutics Inc (EFTR) include a net sale of 609,163 shares made by Sr One Capital Fund I Aggregator Lp ,

In summary, during the past 3 months, insiders sold 0 shares of eFFECTOR Therapeutics Inc (EFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,367 shares of eFFECTOR Therapeutics Inc (EFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,367 shares.

eFFECTOR Therapeutics Inc (EFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

eFFECTOR Therapeutics Inc Insider Transactions

No Available Data

What does Tenaya Therapeutics Inc do?

Who are the key executives at Tenaya Therapeutics Inc?

David V Goeddel is the director & 10 percent owner of Tenaya Therapeutics Inc. Other key executives at Tenaya Therapeutics Inc include director & Chief Executive Officer Faraz Ali , Chief Medical Officer Whittemore Tingley , and Chief Scientific Officer Timothy Hoey .

Tenaya Therapeutics Inc (TNYA) Insider Trades Summary

Over the past 18 months, David V Goeddel made 1 insider transaction in Tenaya Therapeutics Inc (TNYA) with a net purchase of 2,222,222. Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net sale of 25,800 shares made by Timothy Hoey , a net sale of 21,669 shares made by Faraz Ali , and a net sale of 19,491 shares made by Whittemore Tingley .

In summary, during the past 3 months, insiders sold 2,258 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 0 shares, with a net sale of 2,258 shares. During the past 18 months, 81,234 shares of Tenaya Therapeutics Inc (TNYA) were sold and 4,444,444 shares were bought by its insiders, resulting in a net purchase of 4,363,210 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tenaya Therapeutics Inc Insider Transactions

No Available Data

David V Goeddel Mailing Address

Above is the net worth, insider trading, and ownership report for David V Goeddel. You might contact David V Goeddel via mailing address: C/o Column Group Lp, 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on David V Goeddel

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.